Literature DB >> 8020154

Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.

M Stiborová1, R C Fernando, H H Schmeiser, E Frei, W Pfau, M Wiessler.   

Abstract

We report the analysis of DNA adducts in the target organ (forestomach) of male Sprague-Dawley rats treated orally with two doses (10 mg/kg body wt) per week for 2 weeks of either aristolochic acid I (AAI), aristolochic acid II (AAII) or the plant extract aristolochic acid (AA). DNA adducts were detected and quantitated using the nuclease P1-enhanced version of the 32P-postlabelling assay. For identification of adducts, reference compounds were prepared by reaction of enzymatically activated AAI and AAII with 3'-purine phosphonucleosides and analysed by the n-butanol enrichment procedure. These reference compounds were assigned to the previously characterized DNA adducts of AAI [7-(deoxyguanosin-N2-yl)-aristolactam I = dG-AAI, 7-(deoxyadenosin-N6-yl)-aristolactam I = dA-AAI] and AAII [7-(deoxyadenosin-N6-yl)-aristolactam II = dA-AAII]. Cross referencing of the carcinogen-modified nucleoside bisphosphates obtained from forestomach DNA with the synthetic standard compounds by ion-exchange chromatography and reversed-phase HPLC demonstrated that the major DNA adducts formed by AAI and AA were identical to dG-AAI and dA-AAI. Likewise, forestomach DNA isolated from AAII-treated rats showed two purine-derived adduct spots, the major one being dA-AAII, the minor one being tentatively identified as 7-(deoxyguanosin-N2-yl)-aristolactam II. A minor adduct detected in forestomach DNA of rats treated with AAI was found to be chromatographically indistinguishable from the adduct identified as dA-AAII, indicating a possible demethoxylation reaction of AAI. Quantitation of DNA adducts revealed that in in vitro reactions with 3'-phosphonucleosides the adduct levels were approximately one order higher for both AAI- and AAII-derived adducts than in forestomach DNA modified with AAI or AAII in vivo. In vitro as well as in vivo adduction by AAI was more efficient than adduction by AAII. The pattern of adduct spots obtained from forestomach DNA of rats treated with the plant extract AA reflected the composition of the extract determined by HPLC analysis. Irrespective of the aristolochic acid used to induce DNA adducts, deoxyadenosine is the major target of modification, pointing to the general importance of deoxyadenosine adducts for chemical carcinogenesis of these naturally occurring products. This study shows that the combination of two independent chromatographic systems considerably enhances the fidelity of identification of DNA adducts with the 32P-postlabelling assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020154     DOI: 10.1093/carcin/15.6.1187

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

Review 2.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

4.  Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats.

Authors:  L Patrice McDaniel; Elizabeth R Elander; Xiaoqing Guo; Tao Chen; Volker M Arlt; Nan Mei
Journal:  Environ Mol Mutagen       Date:  2012-04-17       Impact factor: 3.216

5.  DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.

Authors:  Nan Mei; Volker M Arlt; David H Phillips; Robert H Heflich; Tao Chen
Journal:  Mutat Res       Date:  2006-09-28       Impact factor: 2.433

6.  Predicting the possibility of two newly isolated phenetheren ring containing compounds from Aristolochia manshuriensis as CDK2 inhibitors.

Authors:  Ali Abdullah Alshatwi; Tarique Noorul Hasan; Naveed Ahmed Syed; Gowhar Shafi
Journal:  Bioinformation       Date:  2011-12-10

Review 7.  Mechanisms of chemical carcinogenesis in the kidneys.

Authors:  Robert Radford; Helena Frain; Michael P Ryan; Craig Slattery; Tara McMorrow
Journal:  Int J Mol Sci       Date:  2013-09-25       Impact factor: 5.923

8.  Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection.

Authors:  Selda Aydin; Anne-France Dekairelle; Jérôme Ambroise; Jean-François Durant; Michel Heusterspreute; Yves Guiot; Jean-Pierre Cosyns; Jean-Luc Gala
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

9.  Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats.

Authors:  Yong-Zhen Liu; Heng-Lei Lu; Xin-Ming Qi; Guo-Zhen Xing; Xin Wang; Pan Yu; Lu Liu; Fang-Fang Yang; Xiao-Lan Ding; Ze-An Zhang; Zhong-Ping Deng; Li-Kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2021-03-08       Impact factor: 7.169

10.  A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.

Authors:  Marie Stiborová; František Bárta; Kateřina Levová; Petr Hodek; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.